Focusing Dead Vaccines: The Corona Vaccine Novavox is soon to be approved in the European Union. A special procedure recently expedited approval.
Updated December 1, 1:45 p.m.: Is it happening much faster than you thought? Nuroxovit, also known as the corona dead vaccine from Novavox, may be recommended for approval by the European Medicines Agency (EMA) before this year. That was loud Drug Newspaper (PZ) Dr. Director of Vaccination Strategy. Marco Cavalieri, known.
May be approved this year, he said. The corona vaccine, one of the protein vaccines, has so far made five vaccines available in the European Union (EU) and Germany. The US-based manufacturer applied for EU approval on November 17. But: EMA has been verifying pre-clinical and clinical data on the so-called rolling review process since February, reports Drug Newspaper Further.
Corona dead vaccines: Novax vaccine neuroxovit vaccine to be approved in EU
The Paul Ehrlich Institute, the Federal Institute for Vaccines and Biomedical Drugs, describes such a “rolling review” as follows: The vaccine candidate was initiated before all the data needed for the marketing accreditation application had been collected. Once all the required data is available, a formal application for approval can be submitted. “
In contrast to the Novavax vaccine, the products of Biontech / Pfizer and Moderna are called mRNA vaccines and the vaccines of Astra-Zeneca and Janssen (Johnson & Johnson) are called vector vaccines. Weekly Magazine Time Recently Toddimstoff explained in a simple way. In the case of classic live vaccines, for example, live pathogens are used, “its pathogenic effects are grown in the laboratory, so let’s talk”. It’s a matter of “harmless germs”. In the case of dead vaccines, on the other hand, “only” structures, for example, proteins from the pathogenic surface are used loudly. Time Recognized by antibodies and cells of the immune system. Sometimes the germs are reproduced and then killed so that they can be managed as a complete “dead” virus. Then called the dead vaccine.
Corona dead vaccines: some vaccine skeptics argue by waiting for this vaccine
Report from December 13: Gaithersburg / USA – Corona epidemic continues to rage, but persists Germany, Austria and Switzerland Fight against loud vaccine resistance. Some skeptics argueAccording to the classic practice * should not be vaccinated until there is a dead vaccine.
This argument cannot be substantiated with facts, but some doubts no longer accept the facts. Can inactivated vaccine Novavox change things?
Corona: Why so many people are waiting for the deadly vaccine
The novovax vaccine is also known as the dead vaccine, which contains elements of the corona virus novel that are killed for immunization. So far, only corona vaccines based on other methods have been approved in the EU: Vaccines Biotech / Pfizer And Modern Based on the new MRNA technology and vector vaccines provided by AstraZeneca and Johnson & Johnson. It is therefore of interest to individuals who make reservations about immunizations through NovaVox, MRNA vaccines or vector vaccines. But there is another reason why Novavox makes a difference in the fight against infections. Unlike the Novavax – Biontech Pfizer vaccine, for example – the drug is considered a beacon of hope for poor countries because it can be stored in the refrigerator at room temperature.
Novavox: When is the vaccine approved?
In November, Indonesia became the first country in the world to recognize the inactivated Novavax vaccine, which was later approved in the Philippines. In mid-November, US pharmaceutical company Novavax applied for EU marketing approval. It was then said that the results would be announced “in a few weeks”. The manufacturer claims that its vaccine is 90 percent effective and 100 percent safe against mild and severe diseases.
In early August, the EU Commission signed a procurement agreement with NovaVox on behalf of member states for up to 100 million vaccine doses this year and next. The agreement also includes options for 100 million vaccine doses in 2021, 2022 and 2023. The German Ministry of Health plans to vaccinate next year. This may be good news, because the manufacturer claims that his vaccine has already been modified Omigron– Customize the variation. The pharmaceutical company has also applied for approval in Canada, Australia, Singapore, Great Britain and New Zealand.
Novavax wants to fix production issues with a new collaboration
In fact, Novavax wants to go further: the pharmaceutical company had planned to deliver billions of doses of vaccine against Kovit-19 by 2021. But production problems thwarted the company’s plans. The pharmaceutical company has already received a $ 1.6 billion grant from the US government, but has repeatedly faced difficulties in complying with quality standards such as Novavax. Forbes Reported. Lack of raw materials also affected production.
In November, Novavax boss Stanley Erck said in an interview CNN, The company will soon send complete data for emergency clearance to the US FDA. Once he gets the green light from the FDA, the first 100 million cans will be ready to ship, the Novavax CEO added. But approval is only available to companies that can provide their funds without restrictions. According to its own information, the company aims to produce more than two billion vaccines in 2022. After all, Novax now has a strong partner: one The company said in a statement The pharmaceutical company has now merged the world’s largest vaccine manufacturer with the Serum Institute of India.
* As Federal Health Minister Carl Lauterbach recently clarified via Twitter, the novovax vaccine is not a deadly vaccine. As the company claims on its website, Novavox is a protein vaccine.(afp / bm)
“Social media maven. Amateur food buff. Pop culture trailblazer. Tv ninja.”